Literature DB >> 31327831

Mid-esophageal Diverticular Bleeding in a Patient with Kyphosis.

Kanako Kishi1, Ryusaku Kusunoki1, Hirofumi Fujishiro1, Shinsuke Suemitsu1, Masatoshi Kataoka1, Aya Fujiwara1, Kosuke Tsukano1, Satoshi Kotani1, Satoshi Yamanouchi1, Masahito Aimi1, Masaki Tanaka2, Youichi Miyaoka2, Tatsuya Miyake3, Naruaki Kohge1, Tomonori Imaoka1, Shunji Ishihara4, Yoshikazu Kinoshita4.   

Abstract

Mid-esophageal diverticulum is a rare disease, formed by the traction caused by inflamed bronchial lymph nodes or by pulsion induced by motility disorder. We herein report a case of mid-esophageal diverticular bleeding in a patient with kyphosis who was taking an anti-platelet drug. She was successfully treated with endoscopic hemostasis. An 80-year-old woman presented to our emergency department with hematemesis. She had kyphosis and was taking dipyridamole for her chest pain. Emergent upper endoscopy revealed bleeding from a mid-esophageal diverticulum; hemostasis was achieved via clipping. Mid-esophageal diverticula can cause upper gastrointestinal bleeding. An endoscopic examination and hemostasis are effective treatments.

Entities:  

Keywords:  diverticular bleeding; mid-esophageal diverticula

Mesh:

Substances:

Year:  2019        PMID: 31327831      PMCID: PMC6911744          DOI: 10.2169/internalmedicine.2951-19

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Gastrointestinal diverticula are usually asymptomatic and need no treatment. Mid-esophageal diverticula, which are true diverticula, develop as a result of traction from inflamed bronchial lymph nodes or pulsion by motility disorder (1). We herein report a rare case of bleeding from a mid-esophageal diverticulum in a patient with kyphosis who was taking an anti-platelet drug. An endoscopic examination and hemostasis with clipping were effective.

Case Report

An 80-year-old woman presented to our emergency department with hematemesis. She had a medical history of chest pain and had been taking dipyridamole after a diagnosis of angina pectoris. On arrival, her blood pressure was 135/74 mmHg, heart rate 89 beats per minute, and body temperature 36.7℃. She complained of nausea but no abdominal pain, melena, or diarrhea. Her laboratory test results were as follows: hemoglobin, 8.4 g/dL; hematocrit, 27.1%. Leukocyte and platelet counts were within normal ranges. An emergency upper endoscopic examination revealed active esophageal bleeding from a small diverticulum at the anterior wall, 25 cm from the incisors (Fig. 1a). A small ulcer at the bottom of the diverticulum was revealed after endoscopic suctioning and inverting the diverticulum into the cap attachment. A hemostatic clip was immediately applied directly to the point of bleeding, the small ulcer at the bottom of the diverticulum. In addition, two hemostatic clips were applied, and the diverticulum opening was sutured (Fig. 1b). Bleeding was stopped with clipping, after which thrombin was sprayed around the diverticulum. A large hiatal hernia was observed. Reflex esophagitis was not observed. The stomach and duodenum appeared normal. Gastric atrophy was not observed on an endoscopic examination, and serum anti Helicobacter pylori IgG antibody was negative. Following the endoscopic hemostasis, the patient was treated with fasting and administered the proton pump inhibitor omeprazole 20 mg by injection 2 times a day.
Figure 1.

(a) An endoscopic examination revealed bleeding from the mid-esophageal diverticulum in the anterior wall. (b) Inverted diverticula during endoscopic hemostasis. (c) A clipping procedure at the bottom and opening of the diverticulum resulted in hemostasis.

(a) An endoscopic examination revealed bleeding from the mid-esophageal diverticulum in the anterior wall. (b) Inverted diverticula during endoscopic hemostasis. (c) A clipping procedure at the bottom and opening of the diverticulum resulted in hemostasis. Contrast-enhanced computed tomography (CT) showed a mid-esophageal diverticulum close to the tracheal bifurcation. Adjacent to the diverticulum, a lymph node with a small calcification was seen, suggesting a cicatrix of tuberculous lymphadenitis (Fig. 2). Diverticula usually develop due to traction from the lymph node. An esophagogram revealed retention of the contrast medium in the diverticulum of the anterior wall (Fig. 3). Because of significant kyphosis in the patient, her esophagus was approximately parallel to the ground in a standing position. There was a large hiatal hernia, and a large quantity of backflow from the stomach was seen. Eight days after admission, upper endoscopy showed three hemoclips on the diverticulum with no bleeding or blood clots.
Figure 2.

Computed tomography (CT) revealed the mid-esophageal diverticulum (arrows) close to the tracheal bifurcation. Adjacent the diverticulum, a lymph node with small calcification (arrowheads) was revealed. (a) Horizontal sectional view, (b) sagittal sectional view.

Figure 3.

An esophagogram, left lateral view, revealed retention of the contrast medium in the diverticulum of the anterior wall (arrows). (a) A large quantity of backflow from the stomach (asterisk) to the esophagus (double asterisk) was shown because of kyphosis and a large hiatal hernia. Vertebrae (dots) and diaphragm (arrowheads) are also shown. (b) Magnifying view of the mid-esophageal diverticulum. A hemoclip remained at the opening of the diverticulum.

Computed tomography (CT) revealed the mid-esophageal diverticulum (arrows) close to the tracheal bifurcation. Adjacent the diverticulum, a lymph node with small calcification (arrowheads) was revealed. (a) Horizontal sectional view, (b) sagittal sectional view. An esophagogram, left lateral view, revealed retention of the contrast medium in the diverticulum of the anterior wall (arrows). (a) A large quantity of backflow from the stomach (asterisk) to the esophagus (double asterisk) was shown because of kyphosis and a large hiatal hernia. Vertebrae (dots) and diaphragm (arrowheads) are also shown. (b) Magnifying view of the mid-esophageal diverticulum. A hemoclip remained at the opening of the diverticulum. After endoscopic hemostasis, the patient remained well with no hematemesis or nausea, and anemia gradually improved without the need for blood transfusion. The administration of dipyridamole was stopped, and omeprazole 20 mg orally once a day was continued. Medical guidance was provided to prevent gastroesophageal reflux. The patient was discharged and continues to be well three years after treatment with no recurrence of gastrointestinal bleeding.

Discussion

We describe two important clinical findings in this case. First, mid-esophageal diverticular bleeding can occur in a patient with kyphosis on an anti-platelet drug; and second, emergent endoscopic hemostasis is effective. Esophageal diverticulum is classified according to its location into three categories: pharyngoesophageal (Zenker), mid-esophageal (Rokitansky), and epiphrenic. Mid-esophageal diverticulum is a true diverticulum, as it comprises all of the layers of the esophageal wall. Mid-esophageal diverticulum develops due to traction from inflamed bronchial lymph nodes. A recent study that reported the high coexistence ratio of motor disorder and mid-esophageal diverticulum suggested that the increase in intraluminal pressure by motility disorder secondarily induces the pulsion mechanism by which the diverticulum develops (1). We did not evaluate the esophageal function in this case. Based on the CT findings, we speculated that the diverticulum of this patient developed due to traction from inflamed bronchial lymph nodes. Esophageal diverticula are usually asymptomatic and rarely come to medical attention. If large or inflammatory diverticula occur associated with dysphagia or odynophagia, surgical resection may be required. Esophageal diverticular bleeding is very rare, and only six cases have been reported to date (2-7). Kyphosis increases the risk of gastroesophageal reflex disease (GERD). GERD is induced by a decrease in the lesser esophageal sphincter (LES) pressure and regurgitation of gastric contents into the esophagus. Hiatal hernia is a major cause of decreased LES pressure and has a positive correlation with the severity of kyphosis (8,9). In this case, as represented by a contrast X-ray examination, the reflux and retention of gastric acid or dietary constituents stimulated mucosal injury in the diverticulum. In a study of seven cases of mid-esophageal diverticular bleeding, four cases, including our own, had coexisting hiatal hernia (Table). Furthermore, in the present case, acid secreted from non-atrophic gastric mucosa might have induced mucosal injury in the diverticulum. Therefore, the administration of a proton-pump inhibitor helped keep the patient well-maintained without recurrence of bleeding for three years.
Table.

Clinical Features of Mid-esophageal Bleeding.

No.ReferenceAge/sexHiatal herniaNSAIDsSizeNumberHemostatic therapy
1255/FYesNoNA2No (spontaneous hemostasis)
2356/FYesNosmall1Surgery
3482/FYesYeslarge1Endoscopic (epinephrine injection)
4556/FNoNosmallmultipleNo (spontaneous hemostasis)
5663/MNoNogiant1Endoscopic (injection therapy + clipping) S-B tube
6761/MNoYeslarge1PEG
7This case83/FYesYessmall1Endoscopic (clipping)

NA: not available, S-B: Sengstaken-Blakemore, PEG: percutaneous endoscopic gastrostomy

Clinical Features of Mid-esophageal Bleeding. NA: not available, S-B: Sengstaken-Blakemore, PEG: percutaneous endoscopic gastrostomy Use of aspirin, other non-steroidal anti-inflammatory drugs (NSAIDs), or anti-platelet drugs increases the risk of diverticular bleeding in the colon (10). NSAIDs, including aspirin, are thought to damage the colonic mucosa via a direct topical effect and/or impaired prostaglandin synthesis, thus compromising the mucosal integrity, increasing the permeability, and enabling the influx of bacteria and other toxins (10). Although the risk factors for esophageal diverticular bleeding are not known, the use of dipyridamole might have induced mucosal injury and bleeding in our patient. In the study mentioned earlier, two patients had been on anti-platelet drugs (Table). A hemostatic approach for mid-esophageal diverticular bleeding has not yet been established. Three cases, including our own, were treated with an endoscopic approach, one was treated with injection therapy, and one was treated with injection therapy and clipping and subsequently with the Sengstaken-Blakemore double (S-B) tube (Table). Endoscopic hemostatic procedures for diverticular bleeding are mostly practiced in the colon. Colonic diverticula are usually small pseudo-diverticula, and colonic diverticular bleeding is the main cause of lower gastrointestinal bleeding. Endoscopic clipping provides a high hemostatic rate, relatively few complications, and a low re-bleeding rate for colonic diverticular bleeding. Endoscopic clipping is divided into two procedures: direct placement, which involves clipping to the bleeding vessel; and indirect placement, which involves clipping and suturing of the opening of the diverticulum. Direct placement reduces the re-bleeding rate from the colonic diverticulum more than indirect placement (11). This is the first case of mid-esophageal diverticular bleeding that was successfully treated with the endoscopic clipping procedure. In our case, kyphosis and the administration of antiplatelet drugs may have induced the mid-esophageal diverticular bleeding, which was effectively treated using the endoscopic hemoclip procedure by direct placement.

The authors state that they have no Conflict of Interest (COI).
  11 in total

1.  MIDESOPHAGEAL DIVERTICULUM WITH HEMORRHAGE: REPORT OF A CASE.

Authors:  O M JONASSON; L C GUNN
Journal:  Arch Surg       Date:  1965-05

2.  An unusual cause of massive upper gastrointestinal bleeding: Dieulafoy's lesion within a giant midesophageal diverticulum.

Authors:  I Turan; A Ozturk; U Akarca; O Ozutemiz
Journal:  Endoscopy       Date:  2008-09       Impact factor: 10.093

3.  Location in the ascending colon is a predictor of refractory colonic diverticular hemorrhage after endoscopic clipping.

Authors:  Naoki Ishii; Nobuto Hirata; Fumio Omata; Toshiyuki Itoh; Masayo Uemura; Michitaka Matsuda; Shoko Suzuki; Yusuke Iizuka; Katsuyuki Fukuda; Yoshiyuki Fujita
Journal:  Gastrointest Endosc       Date:  2012-09-26       Impact factor: 9.427

4.  Esophageal diverticula: pathogenesis, clinical aspects, and natural history.

Authors:  Fernando Antonio Pinto do Nascimento; Eponina M Oliveira Lemme; Milton M B Costa
Journal:  Dysphagia       Date:  2006-07       Impact factor: 3.438

5.  Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding.

Authors:  Lisa L Strate; Yan L Liu; Edward S Huang; Edward L Giovannucci; Andrew T Chan
Journal:  Gastroenterology       Date:  2011-02-12       Impact factor: 22.682

6.  Mid-esophageal traction diverticulum: rare cause of massive upper gastrointestinal bleeding.

Authors:  L E Tucker; T Aquino; W Sasser
Journal:  Mo Med       Date:  1994-03

7.  Presence of vertebral fractures is highly associated with hiatal hernia and reflux esophagitis in Japanese elderly people.

Authors:  Miho Yoshimura; Akihito Nagahara; Keiichi Ohtaka; Yuji Shimada; Daisuke Asaoka; Akihiko Kurosawa; Taro Osada; Masato Kawabe; Mariko Hojo; Takashi Yoshizawa; Sumio Watanabe
Journal:  Intern Med       Date:  2008-08-15       Impact factor: 1.271

8.  Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people.

Authors:  Shiro Imagama; Yukiharu Hasegawa; Norimitsu Wakao; Kenichi Hirano; Nobuyuki Hamajima; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2012-02-28       Impact factor: 3.134

9.  Traction esophageal diverticulum: a rare cause of gastro-intestinal bleeding.

Authors:  Umashankar K Ballehaninna; Jason P Shaw; Igor Brichkov
Journal:  Springerplus       Date:  2012-11-21

10.  Upper gastrointestinal bleed from esophageal diverticula in a patient with dermatomyositis.

Authors:  Mohammad Al-Haddad; Massimo Raimondo
Journal:  Dig Dis Sci       Date:  2006-12-12       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.